Cisplatin	O
reduces	O
endothelial	B-Cell
cell	I-Cell
migration	O
via	O
regulation	O
of	O
type	O
2	O
-	O
matrix	O
metalloproteinase	O
activity	O
.	O

AIMS	O
:	O
In	O
this	O
study	O
we	O
investigated	O
the	O
effect	O
of	O
cisplatin	O
on	O
endothelial	B-Cell
cell	I-Cell
migration	O
,	O
an	O
essential	O
process	O
for	O
vascular	B-Multi-tissue_structure
remodeling	O
and	O
regeneration	O
in	O
several	O
physiological	O
and	O
pathological	O
situations	O
.	O

MATERIAL	O
AND	O
METHODS	O
:	O
Human	B-Cell
umbilical	I-Cell
vein	I-Cell
endothelial	I-Cell
cells	I-Cell
(	O
HUVEC	B-Cell
)	O
were	O
treated	O
with	O
cisplatin	O
and	O
endothelial	B-Cell
cell	I-Cell
migration	O
analyzed	O
by	O
fluorescence	O
and	O
scratch	B-Pathological_formation
-	I-Pathological_formation
wound	I-Pathological_formation
migration	O
assay	O
.	O

MMP2	O
and	O
MMP9	O
activity	O
were	O
determined	O
by	O
zymographic	O
assay	O
,	O
and	O
MAPK	O
activation	O
by	O
Western	O
blotting	O
analysis	O
.	O

RESULTS	O
:	O
We	O
demonstrated	O
that	O
cisplatin	O
provoked	O
a	O
time	O
-	O
and	O
dose	O
-	O
dependent	O
decrease	O
of	O
HUVEC	B-Cell
migration	O
;	O
this	O
effect	O
was	O
clearly	O
independent	O
from	O
its	O
well	O
known	O
cytotoxic	O
activity	O
.	O

In	O
addition	O
,	O
cisplatin	O
markedly	O
reduced	O
MMP2	O
activity	O
in	O
both	O
conditioned	O
media	O
and	O
cell	B-Organism_substance
lysates	I-Organism_substance
,	O
increased	O
p38	O
MAPK	O
and	O
JNK	O
phosphorylation	O
,	O
but	O
did	O
not	O
affect	O
ERK	O
phosphorylation	O
.	O

Endothelial	B-Cell
cell	I-Cell
migration	O
was	O
attenuated	O
by	O
treatment	O
of	O
cells	B-Cell
with	O
GM6001	O
,	O
a	O
non	O
-	O
specific	O
inhibitor	O
of	O
MMPs	O
,	O
or	O
by	O
a	O
selective	O
anti	O
-	O
MMP2	O
antibody	O
.	O

However	O
,	O
treatment	O
of	O
cells	B-Cell
with	O
SB202190	O
or	O
SP600125	O
,	O
inhibitors	O
of	O
p38	O
MAPK	O
and	O
JNK	O
respectively	O
,	O
did	O
not	O
affect	O
HUVEC	B-Cell
migration	O
.	O

CONCLUSION	O
:	O
These	O
results	O
suggested	O
that	O
cisplatin	O
induced	O
a	O
reduction	O
of	O
endothelial	B-Cell
cell	I-Cell
migration	O
through	O
an	O
inhibition	O
of	O
MMP2	O
activity	O
by	O
downstream	O
signal	O
transduction	O
pathways	O
independent	O
of	O
JNK	O
and	O
p38	O
MAPK	O
activation	O
.	O

